Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Obsessive-Compulsive Disorder Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Obsessive-Compulsive Disorder Treatment Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Obsessive-Compulsive Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 ADX-88178
    • 1.4.3 Bitopertin
    • 1.4.4 CR-5542
    • 1.4.5 Dipraglurant IR
    • 1.4.6 Fluvoxamine Maleate
    • 1.4.7 Mavoglurant
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Obsessive-Compulsive Disorder Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Clinic
    • 1.5.3 Hospital
    • 1.5.4 Research Center
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Obsessive-Compulsive Disorder Treatment Market Perspective (2015-2026)
  • 2.2 Global Obsessive-Compulsive Disorder Treatment Growth Trends by Regions
    • 2.2.1 Obsessive-Compulsive Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Obsessive-Compulsive Disorder Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Obsessive-Compulsive Disorder Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Obsessive-Compulsive Disorder Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Obsessive-Compulsive Disorder Treatment Players by Market Size
    • 3.1.1 Global Top Obsessive-Compulsive Disorder Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Obsessive-Compulsive Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Obsessive-Compulsive Disorder Treatment Market Concentration Ratio
    • 3.2.1 Global Obsessive-Compulsive Disorder Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Obsessive-Compulsive Disorder Treatment Revenue in 2019
  • 3.3 Obsessive-Compulsive Disorder Treatment Key Players Head office and Area Served
  • 3.4 Key Players Obsessive-Compulsive Disorder Treatment Product Solution and Service
  • 3.5 Date of Enter into Obsessive-Compulsive Disorder Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Obsessive-Compulsive Disorder Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)
  • 5.2 Global Obsessive-Compulsive Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 6.2 Obsessive-Compulsive Disorder Treatment Key Players in North America (2019-2020)
  • 6.3 North America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 6.4 North America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 7.2 Obsessive-Compulsive Disorder Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 8.2 Obsessive-Compulsive Disorder Treatment Key Players in China (2019-2020)
  • 8.3 China Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 8.4 China Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 9.2 Obsessive-Compulsive Disorder Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 10.2 Obsessive-Compulsive Disorder Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 11.2 Obsessive-Compulsive Disorder Treatment Key Players in India (2019-2020)
  • 11.3 India Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 11.4 India Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Obsessive-Compulsive Disorder Treatment Market Size (2015-2020)
  • 12.2 Obsessive-Compulsive Disorder Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Obsessive-Compulsive Disorder Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AbbVie Inc.
    • 13.1.1 AbbVie Inc. Company Details
    • 13.1.2 AbbVie Inc. Business Overview
    • 13.1.3 AbbVie Inc. Obsessive-Compulsive Disorder Treatment Introduction
    • 13.1.4 AbbVie Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020))
    • 13.1.5 AbbVie Inc. Recent Development
  • 13.2 Addex Therapeutics Ltd
    • 13.2.1 Addex Therapeutics Ltd Company Details
    • 13.2.2 Addex Therapeutics Ltd Business Overview
    • 13.2.3 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Introduction
    • 13.2.4 Addex Therapeutics Ltd Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.2.5 Addex Therapeutics Ltd Recent Development
  • 13.3 C4X Discovery Limited
    • 13.3.1 C4X Discovery Limited Company Details
    • 13.3.2 C4X Discovery Limited Business Overview
    • 13.3.3 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Introduction
    • 13.3.4 C4X Discovery Limited Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.3.5 C4X Discovery Limited Recent Development
  • 13.4 F. Hoffmann-La Roche Ltd.
    • 13.4.1 F. Hoffmann-La Roche Ltd. Company Details
    • 13.4.2 F. Hoffmann-La Roche Ltd. Business Overview
    • 13.4.3 F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Introduction
    • 13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 13.5 Novartis AG
    • 13.5.1 Novartis AG Company Details
    • 13.5.2 Novartis AG Business Overview
    • 13.5.3 Novartis AG Obsessive-Compulsive Disorder Treatment Introduction
    • 13.5.4 Novartis AG Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.5.5 Novartis AG Recent Development
  • 13.6 Omeros Corporation
    • 13.6.1 Omeros Corporation Company Details
    • 13.6.2 Omeros Corporation Business Overview
    • 13.6.3 Omeros Corporation Obsessive-Compulsive Disorder Treatment Introduction
    • 13.6.4 Omeros Corporation Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.6.5 Omeros Corporation Recent Development
  • 13.7 Rottapharm SpA
    • 13.7.1 Rottapharm SpA Company Details
    • 13.7.2 Rottapharm SpA Business Overview
    • 13.7.3 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Introduction
    • 13.7.4 Rottapharm SpA Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.7.5 Rottapharm SpA Recent Development
  • 13.8 Sellas Inc.
    • 13.8.1 Sellas Inc. Company Details
    • 13.8.2 Sellas Inc. Business Overview
    • 13.8.3 Sellas Inc. Obsessive-Compulsive Disorder Treatment Introduction
    • 13.8.4 Sellas Inc. Revenue in Obsessive-Compulsive Disorder Treatment Business (2015-2020)
    • 13.8.5 Sellas Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Obsessive-Compulsive Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obsessive-Compulsive Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    AbbVie Inc.
    Addex Therapeutics Ltd
    C4X Discovery Limited
    F. Hoffmann-La Roche Ltd.
    Novartis AG
    Omeros Corporation
    Rottapharm SpA
    Sellas Inc.

    Market segment by Type, the product can be split into
    ADX-88178
    Bitopertin
    CR-5542
    Dipraglurant IR
    Fluvoxamine Maleate
    Mavoglurant
    Others
    Market segment by Application, split into
    Clinic
    Hospital
    Research Center

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now